A review of novel Cognitive Challenge Tests for the assessment of preclinical Alzheimer's disease.

Rosie E Curiel CidJordi A Matias-GuiuDavid A Loewenstein

Published in: Neuropsychology (2022)

To meet the critical needs of a rapidly evolving field, cognitive assessment instruments must show sufficient scientific rigor including robust sensitivity, specificity, and predictive utility among culturally and linguistically diverse populations and importantly, be correlated to AD biomarkers. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Keyphrases

cognitive decline
emergency department
cell therapy
patient reported outcomes
mild cognitive impairment
structural basis
genetic diversity
drug induced